You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 153 No. 15, 9 AUG 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigations
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reduction in Long-term Antihypertensive Medication Requirements

Effects of Weight Reduction by Dietary Intervention in Overweight Persons With Mild Hypertension

Barry R. Davis, MD, PhD; M. Donald Blaufox, MD, PhD; Albert Oberman, MD; Sylvia Wassertheil-Smoller, PhD; Neal Zimbaldi; Jeffrey A. Cutler, MD; Kent Kirchner, MD; Herbert G. Langford, MD

Arch Intern Med. 1993;153(15):1773-1782.


Abstract

Background
Increasing concern over long-term drug treatment of mild hypertension has stimulated several studies of weight reduction. Phase I of the Trial of Antihypertensive Interventions and Management demonstrated a short-term effect of weight loss on blood pressure control in overweight persons with mild hypertension, who were either taking placebo or taking low-dose monotherapy. Phase II investigates the long-term benefit of weight loss on the ability to maintain blood pressure control.

Methods
From 10 148 community-based screenees, 587 persons (5.8%), aged 21 to 65 years, entered a multicenter, randomized drug (double-blind, placebocontrolled) and diet trial. Participants had a diastolic blood pressure between 90 and 100 mm Hg and were at 110% to 160% of their ideal weight. They were randomized to a usual diet (n=296) or to a weight loss diet (n=291) and within each diet group to placebo, chlorthalidone, 25 mg/d, or atenolol, 50 mg/d. Treatment failure was defined as using additional antihypertensive medications if diastolic blood pressure rose above 90 mm Hg according to protocol-specified criteria.

Results
At baseline, mean diastolic blood pressure was 93 mm Hg; systolic blood pressure, 143 mm Hg; weight, 88 kg; percent ideal weight, 137%; age, 48 years; 56% were men; and 33% were black. Mean follow-up was 4.5 years. There was a net loss of 2 to 3 kg with weight loss diet compared with usual diet over most of the follow-up period. The 5-year incidence of treatment failure was 56.7 per 100 participants with usual diet and 49.8 per 100 with weight loss. Long-term weight loss decreased failure of blood pressure control for those receiving placebo or low-dose diuretic or β-blocker by 23%. The results were similar in direction in each drug group.

Conclusions
The Trial of Antihypertensive Interventions and Management demonstrated that weight reduction is an effective long-term therapy for maintaining blood pressure in the normal range when used as monotherapy or in combination with either thiazide diuretics or β-blockers. Consequently, weight loss should be recommended for the management of obese individuals with mild hypertension.

(Arch Intern Med. 1993;153:1773-1782)



Author Affiliations

From the Coordinating Center for Clinical Trials, University of Texas School of Public Health, Houston (Dr Davis, Mr Zimbaldi); Departments of Nuclear Medicine (Dr Blaufox), Epidemiology—Social Medicine (Dr Wassertheil-Smoller), Albert Einstein College of Medicine, Bronx, NY; Division of General— Preventive Medicine, University of Alabama, Birmingham (Dr Oberman); Division of Epidemiology— Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, Md (Dr Cutler); Department of Medicine, University of Mississippi Medical Center, Jackson (Drs Kirchner and Langford).


Footnotes

Deceased.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A 6-Month Exercise Intervention Among Inactive and Overweight Favela-Residing Women in Brazil : The Caranguejo Exercise Trial
Alves et al.
AJPH 2009;99:76-80.
ABSTRACT | FULL TEXT  

Weight Loss and Blood Pressure Control (Pro)
Harsha and Bray
Hypertension 2008;51:1420-1425.
FULL TEXT  

Long-term Effects of Weight-Reducing Interventions in Hypertensive Patients: Systematic Review and Meta-analysis
Horvath et al.
Arch Intern Med 2008;168:571-580.
ABSTRACT | FULL TEXT  

State of the Art Reviews: Relationship Between Diet/ Physical Activity and Health
O'Neil and Nicklas
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2007;1:457-481.
ABSTRACT  

Meta-analysis: The Effect of Dietary Counseling for Weight Loss
Dansinger et al.
ANN INTERN MED 2007;147:41-50.
ABSTRACT | FULL TEXT  

Weight Loss in Overweight Adults and the Long-term Risk of Hypertension: The Framingham Study
Moore et al.
Arch Intern Med 2005;165:1298-1303.
ABSTRACT | FULL TEXT  

Effects of a 16-Month Randomized Controlled Exercise Trial on Body Weight and Composition in Young, Overweight Men and Women: The Midwest Exercise Trial
Donnelly et al.
Arch Intern Med 2003;163:1343-1350.
ABSTRACT | FULL TEXT  

Differentiated Long-Term Effects of Intentional Weight Loss on Diabetes and Hypertension
Sjostrom et al.
Hypertension 2000;36:20-25.
ABSTRACT | FULL TEXT  

Current and Potential Drugs for Treatment of Obesity
Bray and Greenway
Endocr. Rev. 1999;20:805-875.
ABSTRACT | FULL TEXT  

Nutritional Factors and Hypertension
Lardinois
Arch Fam Med 1995;4:707-713.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.